As per our report, the size of the global digital breast tomosynthesis (DBT) Equipment market was worth USD 1333 million in 2019. This value is projected to grow at a CAGR of 14.14% and will be worth USD 2583 Million by 2024.
DBT is a medical 3D breast imaging technique which is a full-fledged digital mammography system where an X-ray tube rotates round to capture images of the breast from all angles with low radiation dosage and gathered together to view on the monitor.
Growing incidence of breast cancer across the globe is the key factor driving the DBT Equipment market growth.
According to National Breast Cancer Foundation, an estimated 268,600 with invasive breast cancer and 62,930 women with non-invasive (in situ) breast cancer were diagnosed in the United States in 2019, in which, the death expectancy was estimated in 41,760 women. It is also projected, 1 in 8 women in the United States develop breast cancer in their lifetime. Across the world, the North America region is estimated to witness huge demand for this DBT equipment due to the significant growth of breast cancer occurrence in this region.
Growing awareness among people towards 2D & 3D mammography well-developed equipment's for the treatment, and technological advancements in the techniques for the quick diagnosis and detection of breast lesion is further accelerating the market growth. Escalating expenditure on healthcare and rising awareness about the benefits associated with DBT across the world are also contributing to a significant boost to the global digital breast tomosynthesis market growth.
The rising cost of breast cancer treatment & maintenance of installed technology hampers the market growth. Skilled experts or trained lab technicians/radiologists are required to use the equipment, and the shortage of this skilled human resource is expected to impact the growth of the digital breast tomosynthesis market to some level. Shortages of reimbursement policies from the government and non-government bodies and lack of complete knowledge regarding the digital breast tomosynthesis in few of the countries are further expected to obstruct the market growth.
Market Size Available
2018 to 2024
2019 to 2024
By Product, End-User and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East and Africa
This market research report on Global Digital Breast Tomosynthesis (DBT) Equipment Market has been segmented based on the product, end-user and region.
Digital Breast Tomosynthesis (DBT) Equipment Market - By Product
Based on product type, the DBT equipment segment is presently leading the market with the most significant shares and predicted to continue its dominance throughout the forecast period. The growth of this segment majorly attributed due to a moderate increase of breast cancer throughout the world and also having sound knowledge related to the digital breast tomosynthesis is some boosting the market. The market growth is also due to the advantages offered by the new products launched.
3D up-gradation segment is estimated to have a quick growth rate during the forecast period due to the rising awareness among women related to the digital equipment being used is boosting the market growth.
Digital Breast Tomosynthesis (DBT) Equipment Market - By End User
Based on End User, the Hospitals captured larges market share. Its growth rate is projected to be nearly 15% for the forecast period.
Based on the End-User, the hospital's segment is accounted to hold the highest share in terms of revenue and projected to see significant growth in Indian hospitals during the forecast period. This segment is likely to extend with a CAGR of 14.9%, and the increase is due to the extensive records of women with breast cancer and other health problems related to the breast in the hospitals are some factors boosting the market growth.
Diagnostic centres segment is estimated to have quickest growth rate during the period. The increasing number of diagnostic centres globally is considered to accelerate the segment market growth.
IN 2019, North American dominated the global DBT equipment market and estimated to retain its leading position until 2024. The United States accounted for the largest market share in North America. North American countries such as the United States and Canada are having a high prevalence of breast cancer which is estimated to provide immense market growth. Notably, the U.S. has the highest share in North America. This region has a 55.1% share in terms of value. The increase is due to the colossal occurrence of breast cancer and also better healthcare infrastructure provided.
Europe is very close to North America and occupied the second spot in leading the market shares. The U.K. is the leading country of all the nations, and the growth is due to the technological advancements that drive the market. Also, increasing awareness among women about the DBT and its early diagnosis is one factor propelling the market growth. The growth in this market is expected to slow down its growth while coming towards the end of the period.
The Asia Pacific is the fastest-growing market currently and is the most lucrative region for DBT Equipment Market. Within the Asia Pacific, China accounted for the largest market share in this market.
Latin America size was expected to reach a value of USD 266.71 million by 2024 during the forecast period. This region is observed to have sluggish growth steadily throughout the period and also less market perception. In this region, the hospital's segment is accounted to have a growth rate of 15% along the period.
MEA is another region to have inclined growth in the DBT equipment market during the forecast period. This region size is expected to have a value of USD 162.47 billion by 2024, with a CAGR value of 11.6%. The growth in this region is due to low acceptable government policies and is likely to have less penetration market.
TOP COMPANIES IN THE MARKET
Key players operating the global digital breast tomosynthesis (DBT) equipment market profiled in the report are Hologic Inc., Siemens Healthineers, Fujifilm Corporation, G.E. Healthcare, Internazionale Medico Scientifica S.r.l and Planmed Oy.
RECENT MARKET DEVELOPMENTS
On January 24, 2020, Fujifilm Corporation has introduced its new mammography imaging technique with the advanced technologies for Aspire Cristalle, which is a digital breast tomosynthesis includes S-view.
On November 12, 2019, Hologic Inc. received approval from the FDA for its 3DQuorum Imaging Technology which was powered by Genius A.I. This technology works in deuce with high clarity H.D. high-resolution imaging technology that decreases the tomosynthesis image level for radiologists by 66%.
On July 24, 2013, G.E. Healthcare received Ce mark for the approval of SenoClaire tomosynthesis with 3D capacity. This device uses constant restoration of data collected from the images taken when screening or examination of the breast is performed from different angles. Also, the system lowers the dosage used for analysis which helps in detecting breast cancer.
On March 24, 2017, Senographe Pristina system, which is a three-dimensional digital breast tomosynthesis system developed was launched G.E. healthcare. Senographe Pristina has a feature that it can handheld remote control called as Pristina Dueta. Technology enhances the visualization of breast lesions with lower X-ray doses.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 DBT Equipment
5.1.3 3-D Upgradation
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 End User
5.2.3 Diagnostic Centres
5.2.4 Y-o-Y Growth Analysis, By End User
5.2.5 Market Attractiveness Analysis, By End User
5.2.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By End User
6.1.4 Market Attractiveness Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By End User
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Product
220.127.116.11 By End User
6.2 North America
6.2.2 United States
6.4.6 South Korea
6.5 Latin America
6.5.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Hologic Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Siemens Healthineers
8.3 Fujifilm Corporation
8.4 GE Healthcare
8.5 Internazionale Medico Scientifica S.r.l.
8.6 Planmed OY
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures